Six and Twelve Month Changes in Bone Turnover are Related to Reduction in Vertebral Fracture Risk During 3 Years of Raloxifene Treatment in Postmenopausal Osteoporosis

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

Dennis M. Black, Steven R. Cummings, David Karpf et al. · The Lancet · 1996 · 3.9K citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +12

Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>

Bruce Ettinger · JAMA · 1999 · 3.4K citations

Medicine, Pharmacology, Pharmacotherapy +17

Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Steven T. Harris · JAMA · 1999 · 2.5K citations

Medicine, Endocrinology, Bone Augmentation +16

Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women

Pierre D. Delmas, Nina H. Bjarnason, Bruce Mitlak et al. · New England Journal of Medicine · 1997 · 1.6K citations · Full text

Medicine, Gynecology, Pharmacology +17

Pre-Existing Fractures and Bone Mass Predict Vertebral Fracture Incidence in Women

Philip D. Ross, James W. Davis, Robert S. Epstein et al. · Annals of Internal Medicine · 1991 · 1.1K citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17